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ABSTRACT
Objective: To facilitate clinical/genomic/biomedical research, constructing generalizable predictive models us-
ing cross-institutional methods while protecting privacy is imperative. However, state-of-the-art methods as-
sume a “flattened” topology, while real-world research networks may consist of “network-of-networks” which
can imply practical issues including training on small data for rare diseases/conditions, prioritizing locally
trained models, and maintaining models for each level of the hierarchy. In this study, we focus on developing a
hierarchical approach to inherit the benefits of the privacy-preserving methods, retain the advantages of adopt-
ing blockchain, and address practical concerns on a research network-of-networks.
Materials and Methods: We propose a framework to combine level-wise model learning, blockchain-based
model dissemination, and a novel hierarchical consensus algorithm for model ensemble. We developed an ex-
ample implementation HierarchicalChain (hierarchical privacy-preserving modeling on blockchain), evaluated it
on 3 healthcare/genomic datasets, as well as compared its predictive correctness, learning iteration, and execu-
tion time with a state-of-the-art method designed for flattened network topology.
Results: HierarchicalChain improves the predictive correctness for small training datasets and provides compa-
rable correctness results with the competing method with higher learning iteration and similar per-iteration exe-
cution time, inherits the benefits of the privacy-preserving learning and advantages of blockchain technology,
and immutable records models for each level.
Discussion: HierarchicalChain is independent of the core privacy-preserving learning method, as well as of the
underlying blockchain platform. Further studies are warranted for various types of network topology, complex
data, and privacy concerns.
Conclusion: We demonstrated the potential of utilizing the information from the hierarchical network-of-
networks topology to improve prediction.
Key words: blockchain distributed ledger technology, privacy-preserving predictive modeling, hierarchical network, clinical infor-
mation systems, decision support systems
INTRODUCTION
Background and significance
Cross-institutional predictive modeling can accelerate clinical, geno-
mic, and biomedical research1–5 by learning more generalizable mod-
els from the increased number of patient records (Figure 1A). Aiming
at protecting privacy of the patients, several centralized privacy-
preserving algorithms6–9 were developed based on the principle of ex-
changing the models instead of disseminating Protected Health Infor-
mation (PHI) data directly (Figure 1B). Although these approaches
ensured prediction correctness while honoring patients’ privacy, the
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fact that only a central server manages the entire model training pro-
cess creates problems yet to be solved: (1) imbalance in the compute
resource allocation can occur, where the central server can potentially
assign work to a participating healthcare institution unfairly while let-
ting the other institutions remain idle most of time; (2) model parame-
ters in the central server can be modified obliviously during model
training; (3) the provenance (ie, source institution) of models may be
changed by the central server in an undetectable way by local sites;
and (4) information gaps about disseminated models occur between
the central servers with full visibility about generated models and non-
central-servers with only partial visibility.10 These potential concerns
can become hurdles when adopting privacy-preserving learning algo-
rithms among multiple institutions.
To mitigate these risks, a plausible solution is to adopt block-
chain,11 the underlying technology of modern fully decentralized
crypto-currencies (Figure 1C). (1) As a peer-to-peer architecture,12
blockchain can serve as a distributed ledger for the institutions to ex-
change machine learning models without a central server thus re-
A B
D E
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Figure 1. Comparison of privacy-preserving learning methods on different network topologies. A. The participating sites in a flattened network topology, which is
a fully-connected network. The number indicates the size of the records in the database at each site. For a smaller site (eg, s3), the number of records may not be
enough to train a generalizable predictive model, however the direct exchange of data is not preferred due to privacy considerations. B. The centralized learning
methods can build a global model by exchanging the models instead of the data on a flattened network. However, they may have risk concerns such as single
point of control, mutable data/records, change provenance, and partial visibility.10 C. The decentralized methods on a flattened network can address the above-
mentioned privacy risks by having no single point of control, immutable data/records, data provenance, and complete visibility.10 D. The real-world network-of-
networks topology which may contain practical issues such as (1) data size may be small for rare diseases/conditions, (2) each site may prefer to prioritize their lo-
cal data while considering the data size, and (3) each subnetwork may prefer to retain their own models. E. The proposed hierarchical learning method exploiting
the network-of-networks information, which is not fully utilized by the decentralized learning methods designed for a flattened network, to address the practical
issues. Specifically, by computing, recording, and combining the models from each level with different weights based on data size, the hierarchical method aims
at (1) improving predictive correctness with small data (eg, s1), (2) prioritizing local data for each site (eg, s3), and (3) retaining consensus for each subnetwork
(eg, Level 2). It also inherits the advantages of the decentralized method designed for a flattened network.
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moving the concern of a single-point-of-control and potential com-
putational unfairness. (2) The design of the consensus protocols in
blockchain makes the change of the ledger extremely difficult and
therefore ensures the immutability of the models stored on the
blockchain.12 (3) Blockchain also preserves provenance of the led-
ger, which makes the source of the models verifiable.13 (4) Block-
chain is transparent (ie, “everyone can see everything”),13 and
therefore all models are visible to every participating healthcare in-
stitution. It should be noted that although there are many other
existing decentralized architecture (eg, gossiping algorithms14–16)
blockchain contains the above-mentioned technical features (ie, im-
mutability, provenance, and transparency) and has been adopted for
critical financial applications for an extended period of time.11
Therefore, we utilize blockchain as the decentralized architecture to
alleviate the concerns of centralization.
However, the state-of-the-art blockchain-based learning meth-
ods10,17,18 assume that the network has a “flattened” topology, as
shown in Figure 1A. In the real world, the structure of research net-
works can be more complicated than a simple topology. For exam-
ple, PCORnet,19 a major initiative to support an effective,
sustainable national research infrastructure, includes 13 clinical
data research networks (CDRNs). Specifically, pSCANNER,20 one
of the CDRN subnetworks in PCORnet led by University of Califor-
nia San Diego (UCSD), includes subnetworks with data from diverse
sites, and is part of this multi-level “network-of-networks” (ie,
pSCANNER includes SCANNER21 and UCReX22 subnetworks,
with each containing multiple sites).
As shown in Figure 1D, such a real-world network-of-networks
topology can imply practical issues such as (1) small data size for
rare diseases/conditions (eg, Kawasaki Disease23,24), (2) each site
may prefer to prioritize their own model (eg, UCSD may tend to put
more weight on the model learned from local data, while still includ-
ing models from other institutions to increase model generalizabil-
ity) while still considering its data size; and (3) subnetwork model
maintenance (eg, the pSCANNER network may prefer to retain the
aggregated model from its own participating networks in parallel
with the model learned from the whole network such as PCORnet).
Without utilizing the information of the hierarchical topology, the
learning method designed for a flattened topology10,17,18 could not
address these practical issues effectively. As a result, the attempt to
improve the correctness of the cross-institutional predictive model-
ing while preserving patient privacy may not be feasible due to the
insufficiency of the existing methods regarding small data size,
model prioritization, and model maintenance for subnetworks.
Therefore, a hierarchical approach (Figure 1E) that considers the
network-of-networks information is critical to address these issues.
By computing, recording, and combining the models from each level
with different weights based on data size, we anticipate the hierar-
chical method to (1) improve predictive correctness with small data,
(2) prioritize local data for each site while considering the number
of records, and (3) retain consensus for each subnetwork. Also, the
benefits of the methods designed for flattened network (eg, the prop-
erty of fair compute loads for every site of GloreChain10) and the
advantages of adopting a decentralized architecture (ie, no single
point of control, immutable data/records, data provenance, and
complete visibility10) should be inherited.
Objective
We aim at developing a hierarchical modeling framework with 3
goals: (a) inherit the benefits of the privacy-preserving learning
methods designed for flattened network, (b) retain the advantages of
adopting a decentralized architecture, and (c) address practical data
size, local model, and subnetwork consensus issues on a real-world
clinical, genomics and biomedical research network-of-networks.
MATERIALS AND METHODS
To achieve the first goal of inheriting the benefits of the state-of-the-
art learning method at every level of the hierarchical network-of-
network topology (Figure 1E), we adopt the learning methods
designed for a flattened network. With this design, we ensure that at
each level the predictive correctness and fair compute loads proper-
ties are preserved. Next, to retain the advantages of a decentralized
architecture, we utilized peer-to-peer blockchain technology11,13,25–35
to disseminate models and therefore avoid concerns such as single
point of control. Finally, to tackle the practical issues on a real-world
research network-of-networks, we propose to leverage the hierarchical
topology information to store and combine the models from each
level. Figure 2 demonstrates the concept of the proposed hierarchical
consensus learning using an example of pSCANNER, which consists
of 2 subnetworks (SCANNER and UCReX).
We developed HierarchicalChain to evaluate our proposed frame-
work. HierarchicalChain contains the following 3 main components:
1) a level-wise learning method which is originally designed for a flat-
tened network, 2) a blockchain network and its on-chain data struc-
ture, and 3) a hierarchical consensus learning algorithm. These
components are introduced in the next 3 subsections, followed by the
implementation details, datasets, and experiment settings.
Level-wise GloreChain decentralized model learning
Our proposed general framework can adopt both online and batch
decentralized learning algorithms. Online methods, such as Model-
Chain17 and ExplorerChain,18 focus on efficient retraining (ie,
updated model for new data without a complete retrain of the
model). In contrast, batch methods, such as GloreChain,10 empha-
size effective prediction results (ie, learn mode using all data at once
to achieve higher correctness).
For HierarchicalChain, we selected the batch method Glore-
Chain, because we aim at achieving high predictive correctness.
GloreChain also provides an additional advantage of having fair
compute loads for each participating site.10 GloreChain is based on
GLORE,7 a centralized privacy-preserving learning method. We
adapted GloreChain to a level-wise method, such that the consensus
models can be trained at each level of the hierarchical topology (eg,
a total of 7 models learned from 3 levels as shown in Figure 2). We
denote the adapted method as GloreChain-LevelWise.
The blockchain network and on-chain data structure
HierarchicalChain utilized a permissioned blockchain network, in
which only authorized sites (eg, member institutions of consortia
like PCORnet19) can participate. Such a permissioned network
improves privacy protection by prefiltering participants. The incen-
tives for each site and each subnetwork are the improved model gen-
eralizability and thus predictive correctness, as well as the
immutably recorded models for each level of the network-of-
networks. Although the network structure is hierarchical, we use
only one blockchain network to disseminate all models. This simple
design can reduce the maintenance cost.
The transaction metadata of blockchain was exploited to store the
models and related information, as shown in Figure 3. The transaction
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amount are all zeroes because we adopt blockchain as a pure ledger
for data dissemination instead of coin transferring. The details of
the data stored on-chain are explained in Table 1. Compared to
GloreChain,10 we added 4 new fields (ie, “Hierarchy,” “Record,”
“Level,” and “Type”) in HierarchicalChain to incorporate informa-
tion from the hierarchical topology. The space complexity of the
on-chain transaction metadata is O (M2 þ H), where M is the num-
ber of covariates and H is the number of the level of the hierarchy.
By only disseminating partially learned models (ie, aggregated
parameters) on-chain and keeping all observation-level PHI data
off-chain, the privacy of the patient can be preserved.
The Proof-of-Hierarchy consensus learning algorithm
We developed Proof-of-Hierarchy (PoH), a new algorithm to learn
the consensus predictive model on a hierarchical network-of-
networks. First, the consensus models of each level are learned using
GloreChain-LevelWise method. These models are stored on the
single shared blockchain network and thus can be accessed by every
site freely. Finally, to predict the outcome of a new patient data re-
cord, a site computes the prediction scores using all models and
combines the scores to generate the final prediction result.
To combine the scores, we adopted an ensemble approach,
which has been utilized often in biomedical informatics research,
such as in medical information extraction on clinical notes23,39 and
early detection of breast cancer using X-ray images.40 In the PoH al-
gorithm, we exploited 2 simple weighted-average ensemble meth-
ods40: horizontal ensemble and vertical ensemble. The horizontal
ensemble (Figure 4A) combines Level 1 models, weighted by their
training data size, with the intuition that a large institution may pre-
fer to emphasize their own model for the prediction. The vertical en-
semble (Figure 4B) combines all levels of models related to the local
site weighted by the size of each level of network. The intuition of
this method is to consider both the specificity from the small/local
data and the generalizability from the remote/subnetwork data.
Note that although these 2 ensemble methods combine the results
Figure 2. Hierarchical consensus learning. Suppose this 3-level hierarchical network-of-networks consists of 4 sites (Level 1) from 2 subnetworks (SCANNER21
and UCReX22 at Level 2) of an overarching network (pSCANNER20 at Level 3), and we would like to predict a new outcome for site s1. After the consensus models
are learned at each level, we first stored all models (7 in this example), used each of the models to predict the score for the new record (in the test data on site s1),
collected the prediction scores for the new record, and then combined the scores using weighted-average method based on the size of the training data.
Figure 3. Example of block, transaction, and transaction metadata of HierarchicalChain. The predictive model and related information are stored in the transaction
metadata (eg, Metadata of Transaction T11). The 4 red fields (“Hierarchy,” “Record,” “Level,” and “Type”) incorporate the newly added hierarchical information
for HierarchicalChain compared to GloreChain.10 The details of the data fields are described in Table 1.
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from the models of each level of the hierarchical topology, those
models are stored immutably on the blockchain and can be retrieved
at any time as needed.
The details of the PoH algorithm are described in Supplementary
Algorithms A.1, A.2, and A.3 in Appendix A. The main PoH (Supple-
mentary Algorithm A.1) contains both level-wise model learning (Sup-
plementary Algorithm A.2) and horizontal/vertical ensemble
(Supplementary Algorithm A.3). We assume the topology of the
network-of-network is a perfect tree (eg, the network-of-networks
contains 2 sub-networks and each sub-network contains 2 sites; that
is, the number of levels is 3, and the total number of participating sites
is 4). The 5 hyperparameters of PoH includes the polling time period
D, the waiting time period H, the maximum per-level iteration X, the
total number of participating sites N, and the number of levels H.
The implementation of HierarchicalChain
The system architecture of HierarchicalChain is shown in Figure 5.
We implemented PoH, Blockchain-Connector, andGloreChain-Level-
Wise in Java. HierarchicalChain only uses the patient data to compute
the models (in the GloreChain-LevelWise component) without dissem-
inating the data to the blockchain network. We adopted Multi-
Chain27,41 as our blockchain platform, because it is both a system
built on top of the well-known Bitcoin Blockchain11,42 and a permis-
sioned blockchain network for general-purpose ledgering.10,12,18 The
default consensus protocol, Mining Diversity,27,41 is adopted with de-
fault parameters for MultiChain. The system was developed in the
UCSD campus Amazon Web Services (AWS)43,44 and evaluated on
the integrating Data for Analysis, Anonymization, and SHaring
(iDASH) 2.0 cloud network,45,46 a private cloud network also based
on AWS44 and compliant with the Health Insurance Portability and
Accountability Act (HIPAA) requirements. In both cloud networks,
we used Linux-based Virtual Machines (VMs) to simulate 4-site sce-
nario, and the type of each VM is Amazon EC2 T2 Large (ie, 2 virtual
CPUs and 8GB of RAM) with 100GB of storage.47
Datasets
To evaluate the algorithms and models of HierarchicalChain,
we adopted the following 3 datasets, each with one binary outcome:
Table 1. An example of on-chain data of HierarchicalChain. In this example, M¼ 2 is the number of the covariates in the dataset and H¼ 3 is
the number of levels of the hierarchy. The partial model of GloreChain-LevelWise contains both “Model Mean” and “Model Covariance,”
while the final model is the consensus mean vector.7,10 The “Flag” is TRANSFER, representing the submission of a model from 1 site to an-
other via the blockchain. In this round, the model is transferred from the UCReX Site s2 (“From Site”) to the SCANNER Site s1 (“To Site”) at
“2019-06-28 10: 53: 26” (“Time”). The “Hierarchy” of “pSCANNER, UCReX, and UCReX Site s2” represents the subnetworks of the local
site (“UCReX Site s2”), and the number of records on the local site is 30 (“Record”). The “Level” of 3 shows the current learning process
happening on Level 3, and the “Type” of the model is single-level (“SINGLE”). The “Iteration” of 16 is the number of learning iterations at
current level, and the “Result” indicates the value of the evaluation metric for correctness (eg, the full area under the receiver operating
characteristic curve [AUC]).36–38 The 4 newly added fields, compared to GloreChain,10 are marked with an asterisk.
Field Description Possible Values Example
Model
Mean
The mean vector of the GloreChain-
LevelWise partial model7,10
A numerical vector with its length
equals Mþ1
[ 0.676883, 1395.043314, 55.376925 ]
Model
Covariance
The variance-covariance matrix of the Glor-
eChain-LevelWise partial model7,10
A numerical (Mþ1) x (Mþ1) square
symmetric matrix
[ [ 2.164606, 913.081988, 60.973002 ],
[ 913.081988, 1524148.948051,
17102.681580 ], [ 60.973002,
17102.681580, 3334.172388 ] ]
Flag The type of action a site has taken to the
model
UNKNOWN, HIERARCHY,
INITIALIZE, UPDATE,
EVALUATE, TRANSFER,
CONSENSUS, COMPLETE,
TEST, CLEAR
TRANSFER
From Site The site that has submitted the model A unique name or identifier repre-
senting the site
UCReX Site s2
To Site The site which will receive the model A unique name or identifier repre-
senting the site
SCANNER Site s1
Time The time that the site submitted the model A timestamp 2019-06-28 10: 53: 26
Hierarchy * The subnetworks that the local site belong
to
A string vector with its length equals
H and contains unique names or
identifiers of each level of the hier-
archy
pSCANNER,
UCReX,
UCReX Site s2
Record * The number of the records of the local site A non-negative integer 30
Level * The current level of hierarchy for learning
(“1” for ensemble models)
A non-negative integer 3
Type * The type of the model, either single-level
(“SINGLE”) or ensemble
(“HORIZONTAL” or “VERTICAL”)
UNKNOWN,
SINGLE,
HORIZONTAL,
VERTICAL
SINGLE
Iteration The current iteration of the learning process
at current level
A non-negative integer 16
Result The value of the evaluation metric when the
learning process completes
A numerical value between 0 and 1 0.921604
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(1) Edinburg Myocardial Infarction (Edin):48 this dataset includes 9
covariates and 1253 observations with the purpose of predicting the
presence of disease (class distribution: 0.219 positive and 0.781 neg-
ative); (2) Cancer Biomarkers (CA):49 there are 2 covariates and 141
observations to predict the presence of cancer (class distribution:
0.638 positive and 0.362 negative); and (3) Total Hip Arthroplasty
(THA):10,50 the data contains 34 covariates and 960 observations
aiming at predicting extended hospital stay (ie, hospital length of
stay for total hip arthroplasty surgery > 3 days). For the THA data-
set, an IRB Exemption Category 4 (Project Number 190385XX)
was certified by the UCSD Human Research Protections Program
(HRPP) on March 20, 2019.
Experiment settings
Our goal of experiment is to evaluate whether HierarchicalChain
can improve the prediction correctness for practical issues—espe-
cially for small training data—by using the hierarchical topology in-
formation, prioritizing local data, and retaining consensus models
from each level in the hierarchy. We compare the horizontal and
vertical ensemble methods of HierarchicalChain (ie, Hierarchical-
Chain-Horizontal and HierarchicalChain-Vertical) with Glore-
Chain,10 the state-of-the-art blockchain-based decentralized
learning method designed for flattened network topology.
For both HierarchicalChain and GloreChain methods, the preci-
sion of the convergence criterion was 106,7,10 with the following
same hyperparameters based on previous studies,10,18 the network
latency of the cloud networks, and the various sizes and splitting
methods of the data: the polling time period D¼1 (second), the
waiting time period H¼5 (seconds), the maximum per-level itera-
tion X¼100. The latest 4 transactions with the size of the transac-
tion metadata > 20 were checked to identify new transactions on
the blockchain network.
We used the abovementioned 3 datasets (ie, Edin, CA, and THA)
to evaluate the methods. For the hierarchical topology, we set the to-
tal number of participating sites to N¼4, and the total level of hier-
archy to H¼3 (ie, the same topology as shown in Figure 2). That is,
we simulated the network-of-networks by splitting each of the 3
datasets into 4 sites in a hierarchical topology.
To simulate the real-world scenario, we tested 2 different ways
to split the training data among sites: balanced (ie, the number of
records on each site is even) and imbalanced (ie, the number of
records on each site is uneven). Therefore, we split each dataset ran-
domly with (1) balanced ratio of 25% for each site, and (2) imbal-
anced ratios of 10%, 20%, 30%, and 40% for each of the 4 sites,
respectively. For each site, the data was randomly divided into 50%
training and 50% test records. To further evaluate the effect of the
small training data size, we randomly sampled the training data
from 0.1 to 1.0 (using the full training data), in increments of 0.1,
for the Edin and THA datasets. Since the original size of the CA
dataset is already small (141 records), we randomly sampled the
training data from only 0.5 to 1.0, in increments of 0.1. For each
training and test dataset, including the sampled training data, we
preserved a class distribution similar to the original dataset, and
kept at least 1 positive and 1 negative record. Our evaluation metric
is the full area under the receiver operating characteristic curve
(AUC).36–38 We calculated weighted-average AUC on the test data
with the data ratio as the weights (eg, 10%, 20%, 30%, and 40%
for imbalanced data splitting) accounting for both balanced and im-
balanced data-splitting scenarios. We measured consensus iterations
and execution times as well.
The abovementioned process (ie, data splitting, predictive
modeling, and weighted-average test AUC computing) was repeated
30 times to collect the results. For the configuration with the small-
est training sizes, we further conducted a Wilcoxon signed-rank
test51,52 to examine whether the 2 ensemble methods (ie, horizontal
A B
Figure 4. Examples of the ensemble methods adopted in the Proof-of-Hierarchy (PoH) algorithm. A. Horizontal ensemble. For each of the new patient records at
SCANNER Site s1, we first identify all Level 1 sites (ie, SCANNER Site s1, SCANNER Site s2, UCReX Site s3, and UCReX Site s4). The prediction scores from each
Level 1 models (ie, Score1_1, Score1_2, Score1_3, and Score1_4) are then combined using weighted-average with the training data sizes of each site (ie, 10, 30, 40,
and 20 for SCANNER Site s1, SCANNER Site s2, UCReX Site s3, and UCReX Site s4, respectively) as the weights. B. Vertical ensemble. For each of the new patient
records at SCANNER Site s1, we first identify the levels related to SCANNER Site s1, including SCANNER Site s1 itself (Level 1), SCANNER (Level 2), and pSCAN-
NER (Level 3). Then, the prediction scores from the models of each level (ie, Score1_1, Score2_1, and Score3_1) are then combined using weighted-average with
the training data sizes of each level of the hierarchy (ie, 10, 40, and 100, for SCANNER Site s1, SCANNER, and pSCANNER, respectively) as the weights.
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and vertical) of HierarchicalChain perform with statistical signifi-
cant difference when compared with GloreChain in terms of predic-
tive correctness. We reset the blockchain network for each trial to
collect a more accurate execution time.
RESULTS
Predictive correctness
The predictive correctness results on the small training datasets
are shown in Figure 6A. In general, both ensemble methods of
HierarchicalChain outperformed GloreChain. Especially for the
balanced split Edin and THA datasets and the imbalanced split
THA datasets, the differences in AUC were statistically significant
(with P value < .05). For the CA dataset, vertical ensemble per-
formed better on data with both types of splitting methods, and
horizontal ensemble performed better for the balanced split data;
however, all of the results have P value  .05. Also, in almost all
cases (except the horizontal ensemble on CA dataset), Hierarchi-
calChain showed smaller standard deviation when compared with
GloreChain. The results for different training data ratio are
depicted in Figure 6B. In general, HierarchicalChain-Vertical per-
formed similar to GloreChain with a larger training data size,
while HierarchicalChain-Horizontal provided worse correctness
results and was less stable. The lower performance of
HierarchicalChain-Horizontal may be due not using high-level
models (ie, models from Level 2 and Level 3).
Learning iteration
The results of learning iteration on the small training data are shown
in Table 2. In general, HierarchicalChain required 2–10 times of
iterations when compared with GloreChain. The results for different
size of training data are illustrated in Figure 6C. Note that the itera-
tions for HierarchicalChain (computing Level 1, Level 2, and Level
3) were expected to be around 3 times the iterations of GloreChain
(computing only Level 3). While this was true for the full-sized
training data, on smaller training data the variation became larger.
Execution time
The execution time results for the small training data are shown in
Tables 3 and 4. While the total execution times (Table 3) are
roughly in proportion to the learning iterations (Table 2), the per-
iteration execution times (Table 4) demonstrate similar results for
HierarchicalChain and GloreChain. The per-iteration execution
time results for different sizes of training data are depicted in
Figure 6D. In general, the per-iteration time on smaller training data
was also shorter, because the same overhead (eg, initialization time)
Figure 5. System architecture of HierarchicalChain which contains 4 participating sites. The Blockchain-Connector component connects the main Hierarchical-
Chain software to the underlying blockchain platform (MultiChain27,41 in our implementation). Abbreviations: AWS, Amazon Web Services;43,44 iDASH, integrat-
ing Data for Analysis, Anonymization, and Sharing.45,46
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was shared by a larger number of learning iterations. Also, Hier-
archicalChain had lower per-iteration time, because the same over-
head was shared by 3 levels of computation (GloreChain only
computed for 1 level). According to a previous study,10 most of the
execution time was used for waiting/synchronization, and only a
small portion of the time (eg, < 0.2 second10) was used for actual
computation of the models.
DISCUSSION
Findings
According to the results, HierarchicalChain, using vertical ensemble
to combine the models and prioritize the local ones, outperforms
GloreChain for small training data—especially for the THA dataset
collected from UCSD Health. Also, in general, the prediction cor-
rectness of HierarchicalChain is comparable to GloreChain. Despite
the increased learning iterations, the per-iteration execution time of
HierarchicalChain remains at the same level as the one for Glore-
Chain. Additionally, HierarchicalChain inherits the benefits of Glor-
eChain (eg, fair compute loads) and advantages of blockchain (eg,
no single point of control), and can record models for each level on
chain immutably. Finally, HierarchicalChain is more generalizable
than GloreChain. That is, HierarchicalChain can be deployed on a
flattened network, and, in this case, it becomes exactly the same as
GloreChain.
HierarchicalChain, based on GloreChain, can adopt any
privacy-preserving learning algorithms, including both batch and
online methods.10 HierarchicalChain overcomes blockchain confi-
dentiality issues by exchanging models from each level without
transferring patient-level data; avoids the blockchain scalability is-
sue, because the per-iteration learning time (5–30 seconds per itera-
tion) is way longer than the average transaction time of a
blockchain (< 1 second); and mitigates the blockchain 51% attack
issue because of the permissioned network nature.
HierarchicalChain can also adopt different underlying block-
chain platforms. That is, in our experiment, we adopted Multi-
Chain with its low energy-consuming Mining Diversity consensus
protocol; however, any other blockchain platform can also serve
as the peer-to-peer infrastructure. The size of the model in our
experiments is about 5 KB, which is smaller than the default size
limit (2 MB) of MultiChain or other mainstream blockchain plat-
forms.53 Also, the iDASH 2.0 cloud network provides an addi-
tional layer of security protection beyond the permissioned
blockchain network.
Figure 6. The results on data with different training data ratio, including 3 datasets (Edin, CA, and THA) as well as 2 data-splitting methods (balanced and imbal-
anced). We compared 2 ensemble methods (horizontal and ensemble) of HierarchicalChain with the state-of-the-art GloreChain.10 The data are split to balanced
or imbalanced ratios among the sites. A. The predictive correctness results on small training data. The top header represents dataset name (data split ratio). The
models are trained using only small portions of the training data. The evaluation metrics is the weighted-average AUC and the P values are computed using the
Wilcoxon signed-rank test. B. Prediction correctness, measured in weighted-average test AUC for different training data ratio. C. Learning iterations for different
training data ratios. D. Per-iteration execution time measured in seconds for different training data ratios.
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Limitations
The limitations for this work include: (1) Topology. Hierarchical-
Chain was not tested on nonperfect tree topologies, which can con-
tain different site numbers in various levels and may impact the
performance of the correctness, iterations, and execution time; (2)
Data. We did not evaluate on data with a large number of covari-
ates, missing/nonrepresentative data, and highly different data
distribution among the sites or the levels; (3) Advanced privacy con-
cerns. Although this study focused on protecting patient privacy by
having healthcare institutions exchange aggregated machine learn-
ing model without disseminating patient-level data, more advanced
privacy concerns, such as institutional privacy54 (ie, the model may
still reveal some information for the institution) and differential
privacy55 (ie, the patient-level data may be inferred under certain
Figure 6. Continued
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circumstances), were not covered. Also, our method assumed that
each participating institution is “honest but curious,”56 and there-
fore did not deal with the situation where an institution may submit
a malicious model in an attempt to jeopardize the learning process
or to inspect information from other institutions. (4) Ethical, Legal,
and Social Implications (ELSI). We focused on providing a technical
solution and have yet to investigate the ELSI considerations regard-
ing the tradeoff of privacy risks versus patient benefits, which can
depend on the purposes of the analysis (eg, London cholera out-
break,57–60 bioterrorism attack,61,62 or Ebola outbreak63–65).
CONCLUSION
By training the predictive models using level-wise methods, dissemi-
nating the models using a blockchain network, and combining mod-
els using a novel hierarchical consensus learning algorithm, our
privacy-preserving learning framework: 1) improves prediction cor-
rectness especially for the use case of having a small training dataset
for rare diseases/conditions; 2) keeps similar per-iteration execution
time; 3) inherits benefits from decentralized learning and blockchain
technology; and 4) records models of each level, immutably. Al-
though such an improvement may not have clinical significance and
more learning iterations are needed, we demonstrated the potential
of utilizing the information from the hierarchical network-of-
networks topology to improve the prediction. With further evalua-
tions and enhancements, our proposed framework can create more
generalizable predictive models to support clinical/genomic/biomed-
ical studies within real-world research networks.
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Table 2. Learning iteration results on small training data, including both mean and standard deviation (SD). Note that the learning iteration
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limit of the iterations for GloreChain is 100, while the limit for HierarchicalChain is 100 (iterations) x 3 (levels) ¼ 300
Dataset
(Training Data Ratio)
Edin
(0.1)
CA
(0.5)
THA
(0.1)
Iterations Mean (SD) Mean (SD) Mean (SD)
Balanced Data Splitting GloreChain 59.300 (22.968) 5.133 ( 2.871) 66.567 (23.636)
HierarchicalChain 143.983 (28.953) 30.042 (19.370) 126.575 (28.100)
Imbalanced Data Splitting GloreChain 47.967 (20.388) 4.800 ( 3.818) 66.900 (22.716)
HierarchicalChain 131.842 (27.006) 40.608 (25.022) 129.183 (25.776)
Abbreviations: CA, cancer biomarkers; Edin, Edinburg myocardial infarction; THA, total hip arthroplasty.
Table 3. Total execution time results on small training data, including both mean and standard deviation (SD). The measurements are in
seconds and are averaged over 4 sites. The time for HierarchicalChain includes the computation of the model on Level 1, Level 2, and Level
3, as well as the calculation of the horizontal and vertical ensembles
Dataset
(Training Data Ratio)
Edin
(0.1)
CA
(0.5)
THA
(0.1)
Execution Time (Second) Mean (SD) Mean (SD) Mean (SD)
Balanced Data Splitting GloreChain 451.292 (152.107) 89.200 ( 29.019) 515.275 (160.332)
HierarchicalChain 1142.308 (227.684) 522.142 (213.102) 1023.15 (199.914)
Imbalanced Data Splitting GloreChain 382.483 (140.145) 92.733 ( 26.047) 526.033 (159.897)
HierarchicalChain 1094.283 (228.273) 645.392 (284.194) 1095.542 (197.014)
Abbreviations: CA, cancer biomarkers; Edin, Edinburg myocardial infarction; THA, total hip arthroplasty.
Table 4. Per-iteration execution time results (total execution time in Table 3 divided by the average iterations, which are shown in Table 2)
Dataset
(Training Data Ratio)
Edin
(0.1)
CA
(0.5)
THA
(0.1)
Execution Time (Second) Mean (SD) Mean (SD) Mean (SD)
Balanced Data Splitting GloreChain 7.610 (2.565) 17.377 (5.653) 7.741 (2.409)
HierarchicalChain 7.934 (1.581) 17.381 (7.094) 8.083 (1.579)
Imbalanced Data Splitting GloreChain 7.974 (2.922) 19.319 (5.426) 7.863 (2.390)
HierarchicalChain 8.300 (1.731) 15.893 (6.998) 8.481 (1.525)
Abbreviations: CA, cancer biomarkers; Edin, Edinburg myocardial infarction; THA, total hip arthroplasty.
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